INTRODUCTION
roles in the brain, which contributes to cerebral protein synthesis, intermediary metabolism, and interneuronal synaptic transmission. In addition, the essential amino acids, including Met, must be obtained from diets through intestinal absorption and released into the blood supply. Cerebrovascular endothelial cells express specific carriers that mediate the entry and efflux of amino acids across the luminal membranes of the blood-brain barrier (BBB) (2) . The clinical use of 11 C-Met PET for the imaging of brain tumors that has been reported is as follows: diagnostic accuracy, lesion extension or tumor grading assessment, biopsy or treatment planning, and prognosis or therapeutic response prediction (3) . However, ideal methods for the assessment of 11 C-Met PET images remain controversial, although many reports have described the use of visual assessment, tumor-to-normal (T/N) ratio, or the mean and/or maximum standardized uptake value (SUV) (3). Additionally, 11 C-Met is not an ideal tracer because non-tumor lesions reportedly show increased uptake. It is important for nuclear medicine physicians/radiologists to be familiar with the imaging features and pitfalls of 
Physiological Uptake and Normal Variants
The pituitary gland, choroid plexus, and confluence of sinuses frequently appear in areas of physiological uptake. Lesions in these regions are occasionally overlooked or misinterpreted because these regions show relatively higher uptake than those in surrounding tissues. In particular, the pituitary uptake may depend on the hormonal status in female patients. Normal variants, such as hyperostosis or fibrous dysplasia, also show relatively high 11 C-Met uptake, although the underlying mechanism remains unknown ( Fig. 1) . On the other hand, pineal cysts, choroid plexuses cysts, parahippocampal cysts, and Rathke's cleft cysts (Fig.  2) show no or low 11 C-Met uptake. Magnetic resonance imaging (MRI) should precede 11 C-Met PET to check the morphological anatomy of the central nervous system (CNS). The effect of aging on physiological uptake in the brain is limited, although SUV in the normal brains of children is slightly different from that in the normal brains of adults (4). Whether or not the patients should be in the fasting state before 11 C-Met PET is also controversial. In patients with head and neck cancer, one study reported that food intake before 11 C-Met PET can decrease the tumor SUV, although there is no robust evidence showing that the fasted state affects visual interpretation (5) . In typical PET/computed tomography (CT), CT scans can be helpful for identifying lesions and detecting calcification. Additionally, PET/CT can kjronline.org be safely performed in patients with implanted electronic devices, patients for whom MRI is contraindicated, or patients who are allergic to contrast media.
Glioma
Typical high-grade glioma is easily diagnosed by MRI. However, edema or a destroyed BBB in the boundary zone of tumors frequently modifies MRI findings.
11
C-Met PET, as information complementary to that of MRI, is helpful for the delineation of tumors and estimation of histopathological components or cellular activity. The overall sensitivity of 11 C-Met PET for gliomas, including both high-or low-grade gliomas, is estimated to be approximately 76-100% in various studies (3) . In addition, the studies of only lowgrade gliomas reported a sensitivity ranging from 65-85% (2) . For assessment of the histopathological grade of cerebral glioma, 11 C-Met PET does not show clear predictive value through semi-quantitative or visual analyses to date, because of a significant degree of overlap among tumors of several grades (3). However, 11 C-Met uptake is usually higher in high-grade gliomas than in low-grade gliomas kjronline.org ( Fig. 3) . As an exception, gliomatosis cerebri, a high-grade glioma, is occasionally difficult to detect using 11 C-Met PET because of infiltrative invasion into the white matter (Fig. 4) . Additionally, CT images during PET/CT examination may provide clues for diagnosis, e.g., calcification of oligodendroglioma and oligoastrocytoma (Fig. 5) . The diagnosis of rare low-grade glioma is problematic because of its slow growth and the difficulties in histological confirmation. Few reports describe occasional high 11 C-Met uptake of pilocytic astrocytoma or pleomorphic xanthoastrocytoma, which may be pitfalls in the diagnosis of these tumors (6).
C-Met PET for evaluating ependymomas is reported mainly for spinal lesions, and the ependymomas could be detected to a certain degree except for some small lesions (7).
Assessment of Biopsy Planning
The assessment of biopsy sites using 
Differentiation between Tumor Recurrence and Radiation Necrosis
Several studies show that 11 C-Met PET has advantages for distinguishing radiation necrosis from focal recurrence after radiotherapy (3). The mechanism of 11 C-Met uptake in radiation necrosis is different from that in recurrence. Radiation injury leads to passive diffusion across the broken BBB. Theoretically, uptake by recurrent tumors should exceed the uptake after radiation injury; however, the possibility of overlap between these uptakes exists. Actually, different T/N cutoff ratios (1.27-1.9) are also 
Other Brain Tumors
Apparently,
11
C-Met PET is not useful for the diagnosis of brain metastasis in baseline surveys. Fine nodular metastases are difficult to detect using kjronline.org patients with PCNSL (8). However, some cases of PCNSL are more clearly detected using 11 C-Met PET and contrastenhanced MRI than using 18 F-FDG PET (Fig. 6) . In our experience, malignancies under an immunosuppressive state, such as in acquired immunodeficiency syndrome (AIDS) or post-chemotherapy, occasionally present low 11 C-Met uptake of the tumor (Fig. 7) . In patients with CNS germinoma, the tumor-contouring ability of kjronline.org for some malignant tumors is higher than that of 18 F-FDG PET. Importantly, the visual appearance of CNS germinomas differs depending on their location. Suprasellar and pineal lesions are clearly shown to have higher uptakes than those of surrounding structures. On the other hand, lesions at the basal ganglia show higher asymmetrical uptakes (Fig. 8) (9) . The 11 C-Met uptake of several rare low-grade brain tumors has a confusing appearance similar to the images of high-grade gliomas. Therefore, morphological imaging, such as MRI, is required. Biological factors that affect 11 C-Met uptake in these benign tumors that can provide fundamental information for interpreting 11 C-Met PET are not fully examined. Mixed neuronal and glial tumors, such as gangliogliomas and dysembryoplastic (Fig. 9) , including gangliocytoma of Lhermitte-Duclos disease, show higher 11 C-Met uptake than DNTs (Fig. 10) , although their uptakes slightly overlap (10) . Meningiomas, which are the most common primary brain tumors, also show high 11 C-Met uptake.
C-Met PET can be used to evaluate recurrent or residual meningiomas postresection. However, according to a previous study, 11 C-Met uptake of meningiomas is correlated with tumor volume and location, e.g., skull-base tumors have higher uptakes than tumors at other locations but are not correlated with tumor aggressiveness, such as MIB-1 index, tumor-doubling time, or tumor grade (11) . Central neurocytoma, which is a representative benign tumor, is described as having a markedly higher 11 C-Met uptake (Fig. 11) (12) . 
Vascular Diseases

11
C-Met PET imaging for vascular lesions in the brain often yields false-negative results. Increased 11 C-Met uptake in the perivascular mononuclear infiltrate and gliotic reaction in the collagen capsule surrounding hematomas (Fig. 12) , BBB breakdown of infarction, and plugged venous flow of malformation (Fig. 13) are potential mechanisms for positive 11 C-Met findings (13, 14) . To prevent misdiagnosis and unnecessary surgical intervention, MRI or CT should precede any PET examinations for evaluating cranial lesions.
Inflammation and Infection
Several reports speculate that the mechanism of 11 C-Met uptake in inflammation involves increased metabolism and active amino acid transport as a result of the increased density of inflammatory cells, as well as disruption of BBB. Tumefactive demyelination is a representative disease that shows various uptake patterns depending on the disease activity. In addition, 11 C-Met uptake patterns may not necessarily correspond to the enhanced patterns of the lesions (Fig. 14) . Encephalitis exhibits various uptake patterns and degrees even in the same pathogens.
11
C-Met uptake in encephalitis is relatively dependent on the disease activity, although the mechanisms of increased 11 C-Met uptake remain unknown. Sarcoidosis, brain abscess, progressive multifocal leukoencephalopathy, and tuberculoma are also reported as causes of false positives in 11 C-Met PET (15) . In patients with AIDS, 11 C-Met uptake may help distinguish lymphoma from toxoplasmosis. However, several cases of toxoplasmosis show high uptake similar to that of tumors ( Fig. 15) (15) . Current evidence cannot 
Dysplasia and Hamartoma
Focal cortical dysplasia (FCD) or cortical tubers are representative dysplasias having epileptogenic foci. In general, MRI and 18 F-FDG PET usually precede 11 C-Met PET to detect epileptogenic focus.
11
C-Met uptake of FCD is similar to the uptake of other gray matter, a finding that can be helpful for distinguishing FCD from ganglioglioma prior to surgery (10) . However, we occasionally encounter FCD lesions with slightly higher uptake than that of the surrounding cortex ( Fig. 16) (16) . Modification of amino acid transporters, such as by gliotic reaction or hyperperfusion, is a proposed mechanism for positive 11 C-Met uptake in FCD, although a concrete evidence of the mechanism remains unclear. Hamartoma, which is a benign neoplastic heterotrophic lesion, shows uptake similar to that of white matter, a finding that may contribute to accurate diagnosis (Fig. 17) .
CONCLUSIONS
Intracranial lesions show a wide spectrum of 
